Persistent leaks” and “unaddressed contamination issues” are among the problems workers say they witnessed at one of the ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over allegations their premature infant formula can cause a serious gut condition.

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.

Shares of Abbott Laboratories and Reckitt Benckiser Group slid this morning following a Missouri state court granting the plaintiff a retrial in a baby formula case the companies previously won.

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Abbott Laboratories and Reckitt Benckiser Group ... of liability over claims they hid potential risks of their premature-infant formulas. Abbott was down 2.7% at 1:54 p.m. in New York after ...